DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Poly Medicure Limited (POLYMED) share price today?

Poly Medicure Limited (POLYMED) is trading at ₹1,580 on the NSE, down 0.59% on the day. Source: DocStoX.

What is the PE ratio of Poly Medicure Limited?

Poly Medicure Limited has a price-to-earnings (PE) ratio of 49.7 in the Healthcare sector.

What is the market capitalisation of Poly Medicure Limited?

Poly Medicure Limited has a market capitalisation of approximately ₹16,169 crore.

Is Poly Medicure Limited a profitable company?

Poly Medicure Limited generates a return on equity of 10.4% with a net profit margin of 17.1%. That is a modest return on shareholder capital.

What is the 52-week high and low of POLYMED?

Poly Medicure Limited (POLYMED) has traded between ₹1,182 and ₹2,094.3 over the past 52 weeks, against a current price of ₹1,580.

Does Poly Medicure Limited pay a dividend?

Yes. Poly Medicure Limited currently offers a dividend yield of 0.20%. Dividend payments depend on the board's declaration each year.

Poly Medicure Limited

₹1,580.00▼ -9.30 (-0.59%)

POLYMED·NSE·Healthcare

Market Cap

16168.67 Cr

PE Ratio

49.70

Volume

50,929

Day High - Low

1614.90 - 1575.90

52W High-Low

2094.30 - 1182.00

₹1,580.00▼ -9.30 (-0.59%)

Market Cap16168.67 Cr

PE Ratio49.70

Volume50,929

Day High - Low1614.90 - 1575.90

52W High-Low2094.30 - 1182.00

Poly Medicure Limited (POLYMED): company summary

Revenue rose 12.4% annually, reaching ₹1,875 crore, while net profit fell 5.4% year-on-year to ₹321 crore.

Poly Medicure Limited (POLYMED) is a small-cap Healthcare company valued at ₹16,169 crore operating in Medical Equipment & Supplies on the NSE and BSE.

Recent price move: Poly Medicure Limited last traded at ₹1,580, modestly down 0.59% on the day.
Recent developments: On 2026-08-28, the company announced a dividend of ₹3.50 per share, with the ex-date set for that day. Promoter holding remained at 62.42% as of 2026-06-30, while foreign institutional holding decreased by 0.34 percentage points and domestic institutional holding increased by 0.49 percentage points in the quarter.
Financial performance: Revenue rose 12.4% annually, reaching ₹1,875 crore, while net profit fell 5.4% year-on-year to ₹321 crore. The latest quarter saw revenue rise 30.4% compared to the same quarter a year earlier, but net profit dropped 8.3% to ₹85 crore.
Valuation multiples: The stock trades at 49.7 times earnings, a premium to the Healthcare median of 32.0, 5.70 times book value. It yields 0.2%.
Things to watch: Net profit margin narrowed 3.2 percentage points to 17.1%. The latest quarter net profit declined 8.3% despite higher revenue. The stock is 21.8% below its 52-week high.
Where it stands: Poly Medicure Limited reported annual revenue growth of 12.4% and a net profit decline of 5.4% for the fiscal year. The latest quarter showed revenue growth of 30.4% but a net profit drop of 8.3%. The stock is 21.8% below its 52-week high.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

5.5/10

Fair

Fair Value

ROE

10.37%

Average

P/E

49.70x

Expensive

Debt / Equity

0.11

Low

Industry

Healthcare

Medical Equipment & Supplies

Overall View

Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250

Day₹1576

₹1615

52W₹1182

₹2094

DocStoX take

Supported by risk (9.2) and growth (8.4), but held back by valuation (0.0). Risk looks strong at 9.2, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

5.5

/10

Fair

Quality

Solid

ROE 10.4%

Valuation

Expensive

P/E 49.7×

Growth

Strong

Revenue +19.0% 5Y CAGR

Risk

Low risk

D/E 0.11

Momentum

Soft

44% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹1,580

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹16,169 Cr

52W High / Low

₹2094 / ₹1182

Dividend Yield

0.20%

Promoter Holding

62.42%

EPS (TTM)

₹31.79

Book Value

₹306.45

Key highlights

Low leverage — D/E 0.11
Profitable in all of the last 5 years
Revenue compounding 19% a year
Valuation is weak (0.0/10)

4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Medical Equipment & Supplies

Explore Poly Medicure Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Poly Medicure Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Poly Medicure Limited with peers

Poly Medicure Limited vs Sun Pharmaceutical Industries Limited Poly Medicure Limited vs Divi's Laboratories Limited Poly Medicure Limited vs Torrent Pharmaceuticals Limited Poly Medicure Limited vs Apollo Hospitals Enterprise Limited Poly Medicure Limited vs Zydus Lifesciences Limited Poly Medicure Limited vs Laurus Labs Limited

Related tools & concepts

Value Poly Medicure Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

POLYMED newsLatest coverage & filings Open screenerFilter the whole market